MAGNOLIA, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NYSE Amex:PTX) announced today that its Board of Directors authorized the repurchase of up to $5,000,000 in shares of the Company’s common stock.
MAGNOLIA, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NYSE Amex:PTX) announced today that its Board of Directors authorized the repurchase of up to $5,000,000 in shares of the Company’s common stock.
